The Biden administration announced that it is awarding grants to Regeneron, Johnson & Johnson and other leading medical researchers to develop therapeutics to "protect against COVID-19 for years to come," according to the HHS.

The German pharma giant is the latest company to sue the feds over the new Medicare plan, leaving many industry experts wondering if this fight is headed to the Supreme Court.

Among HR professionals, 35% reported a somewhat negative impact on their mental health.

Both health facilities may be in violation of the Minnesota Hospital Agreement, which protects patients from abusive, harassing and deceptive practices when hospitals seek to collect medical debt, according to the state's attorney general.

Evidence so far suggests that reduced HR staffing is accompanied by high employee turnover.

A federal appeals court has reinstated a lawsuit against Walgreens for violating the federal False Claims Act by improperly receiving hundreds of thousands of dollars from Virginia's Medicaid program.

As lawmakers scrutinize the nation's pharmacy benefit managers, the California insurer expects to save $500 million in annual drug costs by replacing most of CVS Health's PBM services by January 2025.

Weeks before the CMS is releasing a list of drugs eligible for price negotiations, the Justice Department filed a motion, contesting the Chamber's move to block the program, claiming the pause would harm the public.